Your browser doesn't support javascript.
loading
Differential Survival and Therapy Benefit of Patients with Breast Cancer Are Characterized by Distinct Epithelial and Immune Cell Microenvironments.
Kester, Lennart; Seinstra, Danielle; van Rossum, Annelot G J; Vennin, Claire; Hoogstraat, Marlous; van der Velden, Daphne; Opdam, Mark; van Werkhoven, Erik; Hahn, Kerstin; Nederlof, Iris; Lips, Ester H; Mandjes, Ingrid A M; van Leeuwen-Stok, A Elise; Canisius, Sander; van Tinteren, Harm; Imholz, Alex L T; Portielje, Johanneke E A; Bos, Monique E M M; Bakker, Sandra D; Rutgers, Emiel J; Horlings, Hugo M; Wesseling, Jelle; Voest, Emile E; Wessels, Lodewyk F A; Kok, Marleen; Oosterkamp, Hendrika M; van Oudenaarden, Alexander; Linn, Sabine C; van Rheenen, Jacco.
Afiliação
  • Kester L; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Seinstra D; Oncode Institute-The Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • van Rossum AGJ; Oncode Institute-Hubrecht Institute- KNAW & University Medical Centre Utrecht, Utrecht, the Netherlands.
  • Vennin C; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Hoogstraat M; Oncode Institute-The Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • van der Velden D; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Opdam M; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • van Werkhoven E; Oncode Institute-The Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Hahn K; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Nederlof I; Oncode Institute-The Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Lips EH; Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Mandjes IAM; Division of Molecular Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • van Leeuwen-Stok AE; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Canisius S; Department of Biometrics, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • van Tinteren H; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Imholz ALT; Oncode Institute-The Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Portielje JEA; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Bos MEMM; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Bakker SD; Data Center, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Rutgers EJ; Dutch Breast Cancer Research Group, BOOG Study Center, Amsterdam, the Netherlands.
  • Horlings HM; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Wesseling J; Division of Molecular Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Voest EE; Department of Biometrics, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Wessels LFA; Department of Medical Oncology, Deventer Ziekenhuis, Deventer, the Netherlands.
  • Kok M; Department of Medical Oncology, HagaZiekenhuis, The Hague, the Netherlands.
  • Oosterkamp HM; Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands.
  • van Oudenaarden A; Department of Internal Oncology, Reinier de Graaf Gasthuis, Delft, the Netherlands.
  • Linn SC; Department of Medical Oncology, Zaans Medisch Centrum, Zaandam, the Netherlands.
  • van Rheenen J; Department of Surgical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
Clin Cancer Res ; 28(5): 960-971, 2022 Mar 01.
Article em En | MEDLINE | ID: mdl-34965952
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama Limite: Female / Humans Idioma: En Revista: Clin Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Holanda
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama Limite: Female / Humans Idioma: En Revista: Clin Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Holanda